$17.51
-1.26-6.71%
At close: Nov 11, 4:00 PM EST
$19.50
0.733.89%
Pre-Market: 8:40 AM EST
Tandem Diabetes Care Inc
TNDMNASDAQ
Tandem Diabetes Care fell 0.1% from $17.53 to $17.51, behind the S&P 500's +12.7%. Its worst day was May 8 (−16.2%), and its low came May 15 at $12.82.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.01 beat the $-0.07 estimate on $290.4M revenue (est. $276.7M); FY revenue guidance of $1.1B–$1.1B against the $1.1B consensus.
+32.7%, the year's best day, on 13M shares, the year's heaviest volume · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $-0.30 beat the $-0.45 estimate on $247.2M revenue (est. $240.2M); FY revenue guidance of $1.1B–$1.1B against the $1.1B consensus.
−16.2%, the year's worst day · S&P 500 +0.8%
Tandem Diabetes Care shares rose 12.8%, while the S&P 500 rose 0.6%.
+12.8% · S&P 500 +0.6%
EPS of $-0.31 beat the $-0.33 estimate on $254.6M revenue (est. $255.0M); FY revenue guidance of $1.1B–$1.1B against the $1.1B consensus.
+19.1% · S&P 500 +0.6%
EPS of $-0.10 beat the $-0.25 estimate on $283.7M revenue (est. $265.7M); FY revenue guidance of $1.1B–$1.1B against the $1.1B consensus.
−6.0% · S&P 500 +0.3%
Where it ended: a close of $17.51 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $0.11, revenue est. $292.2M).
Nothing in the past 12 months.
All TNDM dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TNDM and SPY from Benzinga historical bars. Not investment advice.
